Acceptability of cell substrates for production of biologicals : report of a WHO Study Group.

QR Code

Acceptability of cell substrates for production of biologicals : report of a WHO Study Group.

Saved in:

Bibliographic Details
Corporate Author:	WHO Study Group on Acceptability of Cell Substrates for Production of Biologicals
Format:	Book
Language:	English
Published:	Geneva : World Health Organization, 1987.
Series:	Technical report series (World Health Organization) ; 747.
Subjects:	Vaccines. Biological products. Cellular immunity. Cell line.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

REACTOGENITY OF TICK-BORNE ENCEPHALITIS VACCINE ENCEPUR ADULT AND IMMUNE RESPONSE
by: G. N. Leonova, et al.
Published: (2014-07-01)

Trypsin. Properties and Use in the Production of Biological Medicinal Products
by: S. M. Sukhanova, et al.
Published: (2018-06-01)

CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS
by: I. P. Ivanova, et al.
Published: (2021-10-01)

ELISPOT assay of the SARS-CoV-2 specific T cells immune response
by: V. V. Gerasimova, et al.
Published: (2022-12-01)

Evaluation of the long-term memory T cell in mice after immunization with a live tularemia vaccine
by: A. S. Kartseva, et al.
Published: (2023-06-01)

CELL MEDIATED IMMUNITY IN PATIENTS WITH STAGE II–IV COLORECTAL CANCER WITH OR WITHOUT CIRCULATING TUMOR CELLS
by: E. Y. Zlatnik, et al.
Published: (2020-09-01)

Intranasal trivalent candidate vaccine elicits broad humoral and cellular immunity against pneumococcal pneumonia
by: Fangyu Ren, et al.
Published: (2025-06-01)

WHO expert committee on biological standardization : fifty-third report.
Published: (2004)

Cellular and synaptic properties of molecularly defined neurons in the external globus pallidus
by: Linda M.C. Koene, et al.
Published: (2025-08-01)

Correction of immune status from hospitalized COVID-19-patients with immunotropic drug added to the basic treatment
by: E. A. Khromova, et al.
Published: (2024-01-01)

Co-loaded simvastatin-ginsenoside Rh2 liposomes enhance cellular immune responses as vaccine adjuvants
by: Yinxiu Huang, et al.
Published: (2025-09-01)

Immunological efficacy of Vaccination against Measles in Children with Down syndrome
by: S. P. Kaplina, et al.
Published: (2014-09-01)

Cellular heterogeneity and clonal hematopoiesis of immune system cells in atherosclerosis
by: A. A. Sleptsov
Published: (2022-11-01)

Porcine Trypsin in the Manufacture of Biological Medicinal Products. Risks and Safety Requirements
by: S. M. Sukhanov, et al.
Published: (2018-09-01)

Requirements for diploid allogenic cell lines used for regenerative medicine
by: O. I. Konyushko, et al.
Published: (2018-08-01)

Justification of Methodological Approaches to Identification Testing of Biomedical Cell Products
by: E. V. Melnikova, et al.
Published: (2019-03-01)

Comparative assessment of the immunogenicity of various revaccination regimens against the SARS-CoV-2
by: O. M. Drapkina, et al.
Published: (2023-01-01)

Assessing the Impact of Nanoplastics in Biological Systems: Systematic Review of In Vitro Animal Studies
by: Maria Viana, et al.
Published: (2025-05-01)

International Practice of Storing Human Cell Lines Intended for Clinical Use
by: O. A. Rachinskaya, et al.
Published: (2018-12-01)

Application of Ion Exchange Chromatography in the Development of Technology to Obtain Inactivated Poliovirus Vaccine
by: A. N. Piniaeva, et al.
Published: (2022-11-01)

Use of Cytogenetic Analysis Methods for Assessing the Quality of Cell Lines in Biomedical Cell Products
by: O. A. Rachinskaya, et al.
Published: (2018-03-01)

Advancements in viral vaccine development: from traditional to modern approaches
by: Ankit Kumar, et al.
Published: (2025-07-01)

Association of systemic cellullar immunity with the development of cataract
by: R. E. Osmanov, et al.
Published: (2022-04-01)

The Use of Short Tandem Repeat Analysis for Cell Line Authentication
by: M. D. Khorolsky, et al.
Published: (2019-12-01)

Cellular Agriculture for Production of Cell-Based Seafood
by: Razieh Farzad
Published: (2021-09-01)

Molecular biology of the cell /
Published: (2015)

An introduction to cell biology /
by: Hole, C. B.
Published: (1979)

Breakthrough Infection After a Primary Series of COVID-19 Vaccination Induces Stronger Humoral Immunity and Equivalent Cellular Immunity to the Spike Protein Compared with Booster Shots
by: Yoshifumi Uwamino, et al.
Published: (2025-07-01)

Molecular biology of the cell /
Published: (1989)

The selection of essential drugs : report of a WHO Expert Committee.
Published: (1977)

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Radiation–Oncology Patients: A Systematic Review and Meta-Analysis
by: Paul Thöne, et al.
Published: (2025-06-01)

The selection of essential drugs : second report of the WHO Expert Committee.
Published: (1979)

Assessment of specific T-cell immunity in patients who have been ill and vaccinated against COVID-19
by: T. A. Platonova, et al.
Published: (2022-04-01)

Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines
by: Xuanxuan Zhang, et al.
Published: (2024-12-01)

Nonproprietary names for pharmaceutical substances : twentieth report of the WHO Expert Committee.
Published: (1975)

Evaluation of Cell Line Identity Using RTCA Profiling for Quality Control of Products Containing Viable Human Cells
by: M. A. Vodyakova, et al.
Published: (2023-09-01)

SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors
by: Pavla Taborska, et al.
Published: (2021-12-01)

Clinical trials for cellular therapy products: conclusions reached by foreign regulatory bodies
by: E. V. Melnikova, et al.
Published: (2020-07-01)

Awareness and acceptability of herpes zoster vaccination in people living with HIV
by: Christian Motet, et al.
Published: (2025-08-01)

Results of the study of the immunogenic activity of cell envelopes of Francisella tularensis different subspicies (Report 2)
by: A. V. Korneva, et al.
Published: (2015-02-01)